Application | Comment | Organism |
---|---|---|
medicine | vildagliptin is a potent and selective dipeptidyl peptidase IV inhibitor in development for the treatment of type 2 diabetes that improves glycemic control by enhancing alpha- and beta-cell responsiveness to glucose. Vildagliptin displays approximately dose-proportional pharmacokinetics over the 25-mg to 200-mg dose range, and administration with food has no clinically relevant effect on vildagliptin pharmacokinetics | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
vildagliptin | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
dipeptidyl peptidase IV | - |
Homo sapiens |